Speaker illustration

Ms Danielle Medina-Hernandez

Madrid (Spain)

SGLT2 inhibitor empagliflozin prevents anthracycline-induced cardiotoxicity in a large-animal model

Event: ESC Congress 2024

Topic: Heart Failure

Session: Novel targets against myocardial damage

Thumbnail

Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity

Event: Heart Failure 2023

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 1

Thumbnail